Try our Advanced Search for more refined results
Intellectual Property UK
-
June 23, 2025
Haribo Group Nixes Monster Energy TMs Over Non-Use
Gummy bear maker Haribo group has convinced European officials to nix two Monster Energy trademarks after the sports drink giant failed to provide any evidence that it had genuinely used the signs to sell a myriad of products in the past five years.
-
June 23, 2025
Staffer Can't Ax Amazon's Defense To Russia Tech Sale Claim
A former Amazon employee on Monday lost his bid to strike out the tech giant's defense to his claims that he was fired for blowing the whistle on alleged sales of its facial recognition technology to Russia.
-
June 23, 2025
Dryrobe Claims Rival's Name Confuses Consumers At TM Trial
Outdoor clothing brand Dryrobe said a rival's use of the name "D-Robe" might lead to consumers confusing it with its own successful brand, on the first day of a trademark dispute trial on Monday.
-
June 23, 2025
Univ. Of Calif., Astellas Defend Cancer Drug IP In Dutch Court
The University of California and Astellas Pharma have persuaded a Dutch court to uphold a patent covering prostate cancer drug Xtandi, marking another win in their fight to keep generic versions off the shelves.
-
June 23, 2025
Teva Voids Novartis' European Patent Over Cancer Drug
An appeals board has stripped Novartis of its European patent over a cancer drug following a challenge from Teva, ruling in a decision published Monday that the treatment isn't inventive.
-
June 20, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen Pogust Goodhead face legal action from mining giant BHP Group, Trainline bring a procurement claim against the Department for Transport, Sworders auction house sue Conservative peer Patricia Rawlings, and Nokia hit with a patents claim by Hisense. Here, Law360 looks at these and other new claims in the U.K.
-
June 20, 2025
AstraZeneca Must Give University More Info In IP Rate Battle
A London judge on Friday ordered AstraZeneca to give the University of Sheffield more information about how the pharma giant sublicensed its patented cancer drug amid the university's claims that AstraZeneca lied to get better rates.
-
June 20, 2025
Reckitt Denies Ex-VP's £1M Claim, Cites Trade Secret Breach
Consumer goods company Reckitt has rejected claims that it owes more than £1 million ($1.4 million) to a former senior executive from Russia, arguing that it fired him ahead of the end of his garden leave because he was working with a bidder for part of its business.
-
June 27, 2025
Hogan Lovells Adds IP Duo In Paris From A&O Shearman
Hogan Lovells has broadened its intellectual property litigation bench in Europe with the hire of two heavyweight intellectual property litigators, who join the firm's Paris office as partners from A&O Shearman.
-
June 20, 2025
BBC Confronts AI Biz Perplexity Over Content Scraping
The BBC said Friday that it has threatened to take legal action against Perplexity, an AI-powered search engine, claiming that the company trained its model on the broadcaster's content.
-
June 20, 2025
Janssen Biotech Loses Patent For Lab-Grown Cells
Janssen Biotech has lost its case at a European Patent Office appellate board to patent its method for treating Type 1 diabetes through lab-grown cells, after the patent appeals board agreed with rival Sanofi that its method lacked the required inventive edge.
-
June 20, 2025
Mathys & Squire Appoints New Chief For Consulting Arm
Intellectual property specialist Mathys & Squire LLP said Friday that it has recruited a senior manager at KPMG Law to lead its consulting arm.
-
June 19, 2025
EPO Rejects Narrow Read Of Patent Claims In Landmark Case
The top appeals board at the European Patent Office has ruled that examiners must always look at the description and drawings when interpreting patents, ditching the approach of assessing a patent's claims in isolation.
-
June 19, 2025
Swedish Court Resurrects BSH IP Battle With Electrolux
Sweden's Svea Court of Appeal has resurrected appliance giant BSH's patent infringement claim against rival Electrolux, following a landmark ruling from the European Union's top court that gives BSH the go-ahead to pursue its claim outside the bloc.
-
June 19, 2025
Dior Beats Hong Kong Co.'s 'Dio' TM
European officials have nixed a Hong Kong firm's trademark application for "Dio," ruling that shoppers might think it was somehow linked to the online "Diorverse" range of French luxury brand Christian Dior.
-
June 19, 2025
Formula One 'Surrenders' Rights To Old EU TM
Formula One has lost one of its iconic F1 trademarks after declaring its "total surrender" to European officials, having failed to provide any evidence that it had used the sign in the past five years amid a rebranding campaign.
-
June 19, 2025
Nestlé's Crunch Crumbles After Fitness Brand Challenge
Nestlé has lost its "Crunch" trademark for a chocolate bar after it left a bid by a British sports nutrition company to nix the mark unchallenged, with officials finding the food giant had not put the mark to good use.
-
June 18, 2025
Cycling Brand's 'Brooks' TM Row Gets Fresh Air In Appeal Win
A bicycle gear company has revived its attempt to block a trademark registration by U.S. rival Brooks Running, having convinced an EU appeals board that its saddlebags are a little too close to athletic bags and backpacks aimed at runners.
-
June 18, 2025
Artist Defends 'Fishrot' Apology Spoof As Free Expression
An Icelandic artist urged a London appellate judge Wednesday to give him a chance to override a decision that he could not successfully defend against a claim from the country's largest seafood company alleging he created a spoof website to publish a false apology over a bribery scandal.
-
June 18, 2025
Standards Org. Halts 'Bluetooth Karaoke Microphone' TM Bid
A Bluetooth standards organization has persuaded European Union officials to block a "Bluetooth Karaoke Microphone" trademark application, proving that consumers could connect the mark to the Bluetooth brand.
-
June 18, 2025
EU Court Affirms Decision To Publicize Pesticide Ingredients
An agrochemical company lost its appeal at a European court on Wednesday to block the European Food Safety Authority from releasing a confidential list of ingredients in one of its pesticides in the interest of public knowledge.
-
June 18, 2025
US Biotech Biz Says Rival's Gene Editing Patent Is Invalid
A U.S. biotech company and two manufacturers have denied they infringed a South Korean rival's gene-editing patent, urging a London court to declare the patent invalid.
-
June 17, 2025
EasyGroup Appeals TM Loss To 'Easy Live' Auction Co.
U.K. venture capital conglomerate easyGroup on Tuesday urged a London appellate court to overturn the rejection of its trademark infringement and revocation case against an online auction services provider, arguing a lower court judge had wrongly disregarded evidence of confusion among consumers.
-
June 17, 2025
UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent
The Unified Patent Court's Local Düsseldorf Division has ruled that Curio Bioscience's Seeker Spatial Mapping Kits infringed patents by 10x Genomics, upholding an injunction against the U.S. biotech company's rival in Germany, France and Sweden.
-
June 17, 2025
Music Samples Not Copyright Exempt, Advocate General Says
The pastiche exemption in European Union copyright law does not apply to the reuse of a musical sample in a new song, an adviser to the bloc's top court said Tuesday.
Expert Analysis
-
ITC Seems Unlikely To Stay Investigations For Parallel IPRs
The U.S. International Trade Commission's recent order denying Ocado's attempt to stay a dispute with AutoStore pending resolution of its inter partes review petitions signals that an ITC complainant's patents are effectively shielded from IPR challenges, at least under current Patent Trial and Appeal Board practice, say attorneys at Reichman Jorgensen.
-
A Framework For Evaluating Willingness Of FRAND Licensees
As an increasing number of standard-essential patent cases turn on whether a manufacturer is willing to pay a fair, reasonable and nondiscriminatory royalty for SEPs, Jorge Contreras at the University of Utah identifies conduct that typically indicates willingness or unwillingness, as well as conduct that should be viewed as indeterminate.
-
Opinion
US Should Learn From German Courts Balancing SEP Rights
The German high court's recent decision in Sisvel v. Haier set a productive tone in balancing the rights of patentees and implementers in standard-essential patent disputes, and its understanding of negotiation realities should be followed by the U.S., say Cravath's David Kappos, former U.S. Patent and Trademark Office director, and Daniel Etcovitch.
-
Examining EPO's Strict Approach To AI Patent Disclosure
Because a recent decision by the European Patent Office Boards of Appeal takes a potentially problematic strict approach to disclosure requirements for machine learning-related patent applications, U.S. applicants filing in the EU should disclose several specific data training sets, says Ronny Amirsehhi at Clifford Chance.
-
ITC Dispute May Lead To PTAB Litigation Strategy Shifts
A pending motion to stay the dispute between AutoStore and Ocado at the U.S. International Trade Commission highlights competing timelines of the ITC and Patent Trial and Appeal Board, and has the potential to reshape the typical forum selection strategies for patentees and defense tactics for challengers, say attorneys at Reichman Jorgensen.
-
Opinion
US Courts Should Adjudicate FRAND Rates On A Global Basis
Following the U.K. Supreme Court's recent Unwired Planet v. Huawei decision, U.S. courts should analyze compliance with contracts on fair, reasonable and nondiscriminatory terms by assessing them on a worldwide basis, because global licenses are the only technically and financially sound way to license standard-essential patents, say attorneys at McKool Smith.
-
UK Top Court Ruling May Be Problematic For Global SEP Suits
There are several reasons to question the wisdom of the U.K. Supreme Court's recent ruling that English judges have the power to set extraterritorial licensing royalty rates for standard-essential patents, including that it encourages forum shopping, says Thomas Cotter at the University of Minnesota Law School.
-
UK Ruling Shows Global SEP Enforcement Dilemma
The U.K. Supreme Court's recent ruling that U.K. judges have the power to set extraterritorial licensing royalty rates for standard-essential patents highlights a problem with global patent enforcement coordination and efficiency that could potentially be solved through the Patent Cooperation Treaty, says Roya Ghafele at Oxfirst.
-
Time To Reassess Your Patent Cooperation Treaty Strategy
In light of the trends outlined in the World Intellectual Property Organization's recent annual Patent Cooperation Treaty review, applicants should make decisions on which international search authority to use based on immediate cost, total cost and quality, says Karam Saab at Kilpatrick.
-
German FRAND Decision May Shape Global SEP Landscape
The German high court's recent decision that patent owner Sisvel didn't breach its fair, reasonable and nondiscriminatory patent licensing obligations by refusing to grant Haier a license represents a shift in the standard-essential patent landscape in favor of SEP holders' enforcement freedom, say Erik Puknys and Michelle Rice at Finnegan.
-
Sustainable Food Progress May Close Global Regulatory Gap
As the need for sustainable food production grows, the European sector will likely align with less stringent U.S. regulatory standards, which will further enable U.S. companies to expand globally and lead to more sophisticated intellectual property strategies in all regions, say Jane Hollywood and Fiona Carter at CMS Legal.
-
Cos. Should Assess IP, Contractual Protections For Their AI
Companies should understand the three types of intellectual property protection for safeguarding proprietary artificial intelligence — which is crucial to fighting the pandemic — as well as tools for creating protections when statutory means fall short, say Lori Bennett at Aetion and attorneys at Mayer Brown.
-
Tips For Accelerating Patent Prosecution In China
In light of recent Chinese patent statistics showing at least eight to 10 months to first office action and an average of 22.7 months to final disposition from the date of filing, there are several strategies applicants may explore to speed through examination, say Aaron Wininger at Schwegman Lundberg and Lei Tan at Pujing Chemical.
-
Use Of AI To Treat COVID-19 Shows Novel Inventorship Issues
As technology and medical companies collaborate to deploy artificial intelligence to combat COVID-19, questions arise about how best to protect AI innovations as well as who should get credit as an inventor, say attorneys at Cadwalader.
-
Israel's Generic COVID-19 Drug Licensing Lacks Due Process
The Israel attorney general's special compulsory license for imported generic versions of Abbvie's patented antiviral drug Kaletra to treat COVID-19 does not provide a right of response, a hearing or direct judicial review, says Ephraim Heiliczer at Pearl Cohen.